rs1471962

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000827809.1(ENSG00000307676):​n.33G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 152,184 control chromosomes in the GnomAD database, including 1,259 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1259 hom., cov: 32)

Consequence

ENSG00000307676
ENST00000827809.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.903

Publications

6 publications found
Variant links:
Genes affected
LZTFL1 (HGNC:6741): (leucine zipper transcription factor like 1) This gene encodes a ubiquitously expressed protein that localizes to the cytoplasm. This protein interacts with Bardet-Biedl Syndrome (BBS) proteins and, through its interaction with BBS protein complexes, regulates protein trafficking to the ciliary membrane. Nonsense mutations in this gene cause a form of Bardet-Biedl Syndrome; a ciliopathy characterized in part by polydactyly, obesity, cognitive impairment, hypogonadism, and kidney failure. This gene may also function as a tumor suppressor; possibly by interacting with E-cadherin and the actin cytoskeleton and thereby regulating the transition of epithelial cells to mesenchymal cells. [provided by RefSeq, Aug 2020]
LZTFL1 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome 17
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LZTFL1NM_001405920.1 linkc.27+5425C>G intron_variant Intron 2 of 10 NP_001392849.1
LZTFL1NM_001405921.1 linkc.27+5425C>G intron_variant Intron 2 of 10 NP_001392850.1
LZTFL1NM_001276378.2 linkc.-138+5425C>G intron_variant Intron 2 of 11 NP_001263307.1 Q9NQ48-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000307676ENST00000827809.1 linkn.33G>C non_coding_transcript_exon_variant Exon 1 of 3
LZTFL1ENST00000539217.5 linkc.27+5425C>G intron_variant Intron 2 of 9 2 ENSP00000441784.1 Q9NQ48-3
LZTFL1ENST00000492333.5 linkc.-49+5425C>G intron_variant Intron 2 of 3 4 ENSP00000505957.1 A0A7P0TA24

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17163
AN:
152066
Hom.:
1260
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0315
Gnomad AMI
AF:
0.210
Gnomad AMR
AF:
0.0863
Gnomad ASJ
AF:
0.164
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.0543
Gnomad FIN
AF:
0.184
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.0872
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.113
AC:
17164
AN:
152184
Hom.:
1259
Cov.:
32
AF XY:
0.111
AC XY:
8271
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0314
AC:
1305
AN:
41554
American (AMR)
AF:
0.0864
AC:
1320
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
570
AN:
3470
East Asian (EAS)
AF:
0.00155
AC:
8
AN:
5174
South Asian (SAS)
AF:
0.0543
AC:
262
AN:
4824
European-Finnish (FIN)
AF:
0.184
AC:
1952
AN:
10582
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.167
AC:
11364
AN:
67982
Other (OTH)
AF:
0.0863
AC:
182
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
781
1561
2342
3122
3903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0872
Hom.:
134
Bravo
AF:
0.102
Asia WGS
AF:
0.0350
AC:
122
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.9
DANN
Benign
0.77
PhyloP100
0.90
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1471962; hg19: chr3-45949187; API